News Medicus Pharma Ltd.

Equities

MDCX

CA58471K1030

Market Closed - Toronto S.E. Other stock markets 08:59:03 31/05/2024 pm IST			5-day change	1st Jan Change
1.99 ^CAD	-0.50%		+2.05%	-0.50%

29/05	Medicus Pharma Files Registration Statement for Proposed Initial Public Offering in the United States	MT
25/04	Medicus Pharma Ltd. announced a financing transaction	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Medicus Pharma Files Registration Statement for Proposed Initial Public Offering in the United States	29/05	MT
Medicus Pharma Ltd. Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States	29/05	NE
Medicus Pharma Plans Private Placement for Clinical Development Acceleration	07/05	AQ
Medicus Pharma Ltd. Announces Closing of Private Placement of Convertible Notes	04/05	NE
Canadian Investment Regulatory Organization Trade Resumption - MDCX	26/04	AQ
Medicus Pharma Ltd. Announces Proposed Private Placement of Convertible Notes	26/04	NE
Canadian Investment Regulatory Organization Trading Halt - MDCX	25/04	AQ
Medicus Pharma Ltd. announced a financing transaction	25/04	CI
Medicus Pharma says U.S. FDA has provided comments on Phase 2 Clinical Protocol of SKNJCT-003	28/03	AQ
Medicus Pharma Ltd. Announces the Receipt of Comments from the U.S Food and Drug Administration	21/03	CI
Medicus Pharma Ltd. Receives FDA Comments on Phase 2 Clinical Protocol to Non-Invasively Treat Basal Cell Carcinoma of the Skin	21/03	NE
Medicus Pharma Names COO	05/03	MT
Medicus Pharma Ltd. Announces Appointment of Erica Monaco as Chief Operating Officer	05/03	NE
Medicus Pharma Ltd. Announces the Appointment of Erica Monaco as Chief Operating Officer	05/03	CI
Medicus Pharma Ltd. Publishes the Amended Clinical Study Report from the SKNJCT-001 Phase 1 Safety and Tolerability Study	15/02	CI
Medicus Pharma Ltd. Publishes Phase 1 Clinical Study Report Demonstrating Safety & Tolerability in All Participants with Basal Cell Carcinoma	15/02	NE
Medicus Pharma Ltd. Announces the Filing of a Final Base Shelf Prospectus	26/01	NE
Medicus Pharma Ltd. Announces Listing on Frankfurt Stock Exchange	18/01	NE
Medicus Pharma Ltd. Announces the Submission to the United States Food and Drug Administration A Phase 2 Investigational New Drug Clinical Protocol (SKNJCT-003)	03/01	CI
Medicus Pharma Ltd. Submits to the FDA Phase 2 IND Clinical Protocol to Non-Invasively Treat Basal Cell Carcinoma of the Skin	03/01	NE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Medicus Pharma Ltd.

Equities

MDCX

CA58471K1030

Summary

Filters